Charles Greg Guyer - May 3, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
May 3, 2024
Transactions value $
-$349,215
Form type
4
Date filed
5/7/2024, 05:58 PM
Previous filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock +Grant/Award $16,818 +245 +0.31% $68.65 78,572 Apr 30, 2024 Direct F1
transaction BMRN Common Stock -Tax liability -$366,034 -4,440 -5.65% $82.44 74,132 May 3, 2024 Direct

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.